Price
No data yet.
Social Signal Score
Analyst Ratings
15 analystsRevenue
$479.60M+20.33%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Theodore Wahl
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Employees
- 36,000
- Beta
- 0.81
- Country
- US
- Piotroski score
- 7 / 9 (Strong)
- Altman Z-score
- 7.06
Financials
Revenue
$479.60M+20.3%Net Income
$24.88M+22.6%EBITDA
$37.78M+17.0%Free Cash Flow
$28.10M+1327.9%EPS (diluted)
$0.36+28.6%Shares Outstanding (diluted)
69.38M-5.7%Operating Expenses
$48.45MCash & Debt
$204.19MReturn of Capital
$11.74MRevenue by Segment (annual)
$1.84BDividend per Share
$0.21Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $1.84B | $59.06M | $0.82 |
| 2024 | $1.72B | $39.47M | $0.54 |
| 2023 | $1.67B | $38.39M | $0.52 |
| 2022 | $1.69B | $34.24M | $0.46 |
| 2021 | $1.64B | $48.54M | $0.65 |
| 2020 | $1.76B | $98.68M | $1.32 |
| 2019 | $1.84B | $64.58M | $0.87 |
| 2018 | $2.01B | $83.52M | $1.13 |
| 2017 | $1.87B | $88.23M | $1.20 |
| 2016 | $1.56B | $77.40M | $1.06 |
| 2015 | $1.44B | $58.02M | $0.81 |
| 2014 | $1.29B | $21.85M | $0.31 |
| 2013 | $1.15B | $47.13M | $0.68 |
| 2012 | $1.08B | $44.21M | $0.65 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from HCSG's reported EPS growth of 1.8% a year over 13 years.
- EPS in 5 years
- $0.89
- Implied price
- $20.52
- Return from $25.30
- -4.1% a year
To earn 15.0% a year on these assumptions you'd need to buy at $10.20 — -59.7% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 17 | 20 | 23 | 26 | 29 |
|---|---|---|---|---|---|
| -8.2% | -18.6% | -15.9% | -13.5% | -11.4% | -9.4% |
| -3.2% | -14.2% | -11.3% | -8.8% | -6.5% | -4.5% |
| 1.8% | -9.7% | -6.7% | -4.1% | -1.7% | 0.4% |
| 6.8% | -5.3% | -2.2% | 0.6% | 3.1% | 5.4% |
| 11.8% | -0.9% | 2.4% | 5.3% | 7.9% | 10.3% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
50+66.67%Social Signal Score
Mentions (6)
- Newszacks.com·1d ago·Neutral
Healthcare Services (HCSG) Is Up 2.62% in One Week: What You Should Know Does Healthcare Services (HCSG) have what it takes to be a top stock pick for momentum investors? Let's find out.
View source ↗ - Newsseekingalpha.com·3d ago·Positive
Healthcare Services Group, Inc. (HCSG) Q3 2026 Earnings Call Transcript Healthcare Services Group, Inc. (HCSG) Q3 2026 Earnings Call Transcript
View source ↗ - Newszacks.com·3d ago·Positive
Healthcare Services (HCSG) Q3 Earnings Surpass Estimates Healthcare Services (HCSG) came out with quarterly earnings of $0.36 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.23 per share a year ago.
View source ↗ - Newszacks.com·9d ago·Neutral
Healthcare Services Group Gears Up for Q3 Earnings: What's in Store? Healthcare Services Group, Inc. HCSG is scheduled to release third-quarter 2026 results on Oct. 21, before market open.
View source ↗ - Newszacks.com·45d ago·Positive
Healthcare Services (HCSG) Upgraded to Strong Buy: Here's What You Should Know Healthcare Services (HCSG) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
View source ↗ - Newszacks.com·47d ago·Negative
Is Healthcare Services Group (HCSG) Stock Outpacing Its Business Services Peers This Year? Here is how Healthcare Services (HCSG) and Marsh (MRSH) have performed compared to their sector so far this year.
View source ↗
Earnings
Wed, Feb 10(in 4 months)
Consensus estimate $0.24 per share
Typical surprise +42.5% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Oct 21$0.36 vs $0.24beat
- Wed, Jul 22$0.32 vs $0.22beat
- Wed, Apr 22$0.37 vs $0.22beat
- Wed, Feb 11$0.44 vs $0.23beat
- Wed, Oct 22$0.23 vs $0.21beat
- Wed, Jul 23$0.21 vs $0.20beat
Estimates and results for HCSG via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by HCSG officers and directors.
- Bought
- —
- Sold
- $3.4m
0 trades
7 trades
- Kush Andrewsold
- Brophy Andrew Msold
- Orr Patrick Jsold
- Orr Patrick Jsold
- Orr Patrick Jsold
- Shea John Christophersold
- Shea John Christophersold
93 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Greg Gianfortehouse · MT00 · disclosed May 7, 2020 (7d later)Buy$50,001 - $100,000
- Donna Shalalahouse · FL27 · disclosed Apr 27, 2020 (308d later)Sell$1,001 - $15,000
- Greg Gianfortehouse · MT00 · disclosed Nov 27, 2019 (47d later)Buy$100,001 - $250,000
- Greg Gianfortehouse · MT00 · disclosed Oct 20, 2019 (40d later)Sell$100,001 - $250,000
- Gilbert Cisneroshouse · CA39 · disclosed May 14, 2019 (12d later)Sell$1,001 - $15,000
- Gilbert Cisneroshouse · CA39 · disclosed Apr 16, 2019 (26d later)Sell$1,001 - $15,000
- Carlos Curbelohouse · FL26 · disclosed Sep 25, 2018 (28d later)Buy$1,001 - $15,000
- Thomas Roland Tillissenate · NC · disclosed Feb 26, 2015 (13d later)Sell$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
